US Stock MarketDetailed Quotes

KZR Kezar Life Sciences

Watchlist
  • 0.633
  • +0.003+0.52%
Close Jul 22 16:00 ET
  • 0.644
  • +0.011+1.72%
Post 19:37 ET
46.11MMarket Cap-455P/E (TTM)

Kezar Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-9.60%-22.86M
-38.74%-81.65M
-19.50%-18.98M
-23.50%-20.21M
-62.54%-21.6M
-56.68%-20.86M
-38.67%-58.85M
-43.34%-15.88M
-64.36%-16.36M
-1.87%-13.29M
Net income from continuing operations
2.44%-21.66M
-49.28%-101.87M
-77.44%-32.26M
-29.45%-23.1M
-50.17%-24.31M
-38.54%-22.2M
-24.91%-68.24M
-27.93%-18.18M
-23.41%-17.85M
-24.88%-16.19M
Operating gains losses
----
----
----
----
----
----
----
----
--0
----
Depreciation and amortization
0.39%260K
4.20%1.07M
198.94%280K
-39.30%278K
-42.23%249K
-37.89%259K
-32.25%1.02M
-173.13%-283K
21.16%458K
15.55%431K
Other non cash items
8.47%64K
6.25%238K
-6.06%62K
11.54%58K
11.32%59K
11.32%59K
146.15%224K
--66K
--52K
--53K
Change In working capital
-125.57%-3.45M
205.54%4.71M
14,287.93%8.35M
-5.63%-2.31M
117.64%199K
-27.10%-1.53M
-463.70%-4.46M
-87.99%58K
-218.55%-2.19M
61.42%-1.13M
-Change in prepaid assets
-114.82%-237K
161.91%3.58M
1,095.20%5.39M
145.17%1.83M
-374.30%-5.24M
1,959.30%1.6M
-650.62%-5.79M
-177.99%-542K
-1,175.33%-4.05M
-10.39%-1.11M
-Change in payables and accrued expense
-322.39%-3.01M
249.89%6.35M
379.50%959K
35.00%2.94M
301.46%1.1M
262.23%1.35M
49.06%1.81M
233.33%200K
25.45%2.17M
116.47%274K
-Change in other current assets
102.13%94K
----
----
----
----
---4.41M
----
----
----
----
-Change in other working capital
-343.28%-297K
-974.90%-5.22M
-1,352.00%-5.01M
----
----
76.33%-67K
53.36%-486K
--400K
----
----
Cash from discontinued investing activities
Operating cash flow
-9.60%-22.86M
-38.74%-81.65M
-19.50%-18.98M
-23.50%-20.21M
-62.54%-21.6M
-56.68%-20.86M
-38.67%-58.85M
-43.34%-15.88M
-64.36%-16.36M
-1.87%-13.29M
Investing cash flow
Cash flow from continuing investing activities
24.51%20.41M
183.21%76.05M
421.88%27.88M
175.17%18.57M
774.37%13.2M
127.53%16.39M
-221.31%-91.39M
89.50%-8.66M
-164.20%-24.71M
-90.71%1.51M
Net PPE purchase and sale
--0
-14.39%-1.81M
99.71%-1K
78.28%-131K
-656.04%-1.38M
34.00%-297K
-399.37%-1.58M
-28.95%-343K
-2,219.23%-603K
-658.33%-182K
Net investment purchase and sale
22.29%20.41M
186.68%77.85M
435.16%27.88M
177.60%18.71M
761.64%14.58M
128.25%16.69M
-219.30%-89.81M
89.88%-8.32M
-162.59%-24.11M
-89.60%1.69M
Cash from discontinued investing activities
Investing cash flow
24.51%20.41M
183.21%76.05M
421.88%27.88M
175.17%18.57M
774.37%13.2M
127.53%16.39M
-221.31%-91.39M
89.50%-8.66M
-164.20%-24.71M
-90.71%1.51M
Financing cash flow
Cash flow from continuing financing activities
0
-99.50%638K
-88.34%59K
-76.76%43K
-99.51%382K
-99.68%154K
13.57%127.86M
-99.49%506K
-91.64%185K
27,673.76%78.32M
Net issuance payments of debt
----
--0
----
----
----
----
--0
----
----
----
Net common stock issuance
--0
--0
28.78%-579K
-76.76%43K
-99.51%382K
-99.68%154K
25.33%126.54M
-100.93%-813K
-91.64%185K
27,673.76%78.32M
Proceeds from stock option exercised by employees
----
-51.63%638K
----
----
----
----
-36.71%1.32M
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-99.50%638K
-88.34%59K
-76.76%43K
-99.51%382K
-99.68%154K
13.57%127.86M
-99.49%506K
-91.64%185K
27,673.76%78.32M
Net cash flow
Beginning cash position
-12.27%35.49M
-35.66%40.46M
-58.89%26.5M
-73.33%28.11M
-7.14%36.13M
-35.66%40.46M
196.22%62.88M
12.89%64.45M
299.47%105.39M
69.84%38.91M
Current changes in cash
43.13%-2.45M
77.83%-4.96M
137.26%8.96M
96.12%-1.59M
-112.04%-8.02M
82.02%-4.32M
-153.66%-22.38M
-515.59%-24.04M
-232.99%-40.88M
1,808.32%66.54M
Effect of exchange rate changes
41.67%-7K
95.92%-2K
-7.32%38K
54.90%-23K
92.19%-5K
-148.00%-12K
2.00%-49K
925.00%41K
-70.00%-51K
-392.31%-64K
End cash Position
-8.57%33.03M
-12.27%35.49M
-12.27%35.49M
-58.89%26.5M
-73.33%28.11M
-7.14%36.13M
-35.66%40.46M
-35.66%40.46M
12.89%64.45M
299.47%105.39M
Free cash flow
-8.06%-22.86M
-38.12%-83.46M
-16.98%-18.98M
-19.91%-20.34M
-70.56%-22.98M
-53.71%-21.16M
-41.33%-60.42M
-43.00%-16.23M
-69.97%-16.96M
-3.08%-13.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -9.60%-22.86M-38.74%-81.65M-19.50%-18.98M-23.50%-20.21M-62.54%-21.6M-56.68%-20.86M-38.67%-58.85M-43.34%-15.88M-64.36%-16.36M-1.87%-13.29M
Net income from continuing operations 2.44%-21.66M-49.28%-101.87M-77.44%-32.26M-29.45%-23.1M-50.17%-24.31M-38.54%-22.2M-24.91%-68.24M-27.93%-18.18M-23.41%-17.85M-24.88%-16.19M
Operating gains losses ----------------------------------0----
Depreciation and amortization 0.39%260K4.20%1.07M198.94%280K-39.30%278K-42.23%249K-37.89%259K-32.25%1.02M-173.13%-283K21.16%458K15.55%431K
Other non cash items 8.47%64K6.25%238K-6.06%62K11.54%58K11.32%59K11.32%59K146.15%224K--66K--52K--53K
Change In working capital -125.57%-3.45M205.54%4.71M14,287.93%8.35M-5.63%-2.31M117.64%199K-27.10%-1.53M-463.70%-4.46M-87.99%58K-218.55%-2.19M61.42%-1.13M
-Change in prepaid assets -114.82%-237K161.91%3.58M1,095.20%5.39M145.17%1.83M-374.30%-5.24M1,959.30%1.6M-650.62%-5.79M-177.99%-542K-1,175.33%-4.05M-10.39%-1.11M
-Change in payables and accrued expense -322.39%-3.01M249.89%6.35M379.50%959K35.00%2.94M301.46%1.1M262.23%1.35M49.06%1.81M233.33%200K25.45%2.17M116.47%274K
-Change in other current assets 102.13%94K-------------------4.41M----------------
-Change in other working capital -343.28%-297K-974.90%-5.22M-1,352.00%-5.01M--------76.33%-67K53.36%-486K--400K--------
Cash from discontinued investing activities
Operating cash flow -9.60%-22.86M-38.74%-81.65M-19.50%-18.98M-23.50%-20.21M-62.54%-21.6M-56.68%-20.86M-38.67%-58.85M-43.34%-15.88M-64.36%-16.36M-1.87%-13.29M
Investing cash flow
Cash flow from continuing investing activities 24.51%20.41M183.21%76.05M421.88%27.88M175.17%18.57M774.37%13.2M127.53%16.39M-221.31%-91.39M89.50%-8.66M-164.20%-24.71M-90.71%1.51M
Net PPE purchase and sale --0-14.39%-1.81M99.71%-1K78.28%-131K-656.04%-1.38M34.00%-297K-399.37%-1.58M-28.95%-343K-2,219.23%-603K-658.33%-182K
Net investment purchase and sale 22.29%20.41M186.68%77.85M435.16%27.88M177.60%18.71M761.64%14.58M128.25%16.69M-219.30%-89.81M89.88%-8.32M-162.59%-24.11M-89.60%1.69M
Cash from discontinued investing activities
Investing cash flow 24.51%20.41M183.21%76.05M421.88%27.88M175.17%18.57M774.37%13.2M127.53%16.39M-221.31%-91.39M89.50%-8.66M-164.20%-24.71M-90.71%1.51M
Financing cash flow
Cash flow from continuing financing activities 0-99.50%638K-88.34%59K-76.76%43K-99.51%382K-99.68%154K13.57%127.86M-99.49%506K-91.64%185K27,673.76%78.32M
Net issuance payments of debt ------0------------------0------------
Net common stock issuance --0--028.78%-579K-76.76%43K-99.51%382K-99.68%154K25.33%126.54M-100.93%-813K-91.64%185K27,673.76%78.32M
Proceeds from stock option exercised by employees -----51.63%638K-----------------36.71%1.32M------------
Cash from discontinued financing activities
Financing cash flow --0-99.50%638K-88.34%59K-76.76%43K-99.51%382K-99.68%154K13.57%127.86M-99.49%506K-91.64%185K27,673.76%78.32M
Net cash flow
Beginning cash position -12.27%35.49M-35.66%40.46M-58.89%26.5M-73.33%28.11M-7.14%36.13M-35.66%40.46M196.22%62.88M12.89%64.45M299.47%105.39M69.84%38.91M
Current changes in cash 43.13%-2.45M77.83%-4.96M137.26%8.96M96.12%-1.59M-112.04%-8.02M82.02%-4.32M-153.66%-22.38M-515.59%-24.04M-232.99%-40.88M1,808.32%66.54M
Effect of exchange rate changes 41.67%-7K95.92%-2K-7.32%38K54.90%-23K92.19%-5K-148.00%-12K2.00%-49K925.00%41K-70.00%-51K-392.31%-64K
End cash Position -8.57%33.03M-12.27%35.49M-12.27%35.49M-58.89%26.5M-73.33%28.11M-7.14%36.13M-35.66%40.46M-35.66%40.46M12.89%64.45M299.47%105.39M
Free cash flow -8.06%-22.86M-38.12%-83.46M-16.98%-18.98M-19.91%-20.34M-70.56%-22.98M-53.71%-21.16M-41.33%-60.42M-43.00%-16.23M-69.97%-16.96M-3.08%-13.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg